Prof. Jun cheng | Public Health | Best Researcher Award

director of dept. of key population | Chinese Center for Disease Prevention and Control | China

Dr. Jun Cheng is a prominent figure in tuberculosis (TB) prevention and control in China, currently serving as the Director of the Department of Key Population at the National Center for Tuberculosis Prevention and Control, Chinese Center for Disease Prevention and Control (China CDC). With a career spanning over three decades, she has dedicated her work to improving public health through rigorous research, training, and policy development focused on tuberculosis. Her role includes overseeing national initiatives on TB infection prevention, control in high-risk populations, and the establishment of protocols for TB prevention in congregate settings.

Profile

Orcid

Education:

Dr. Cheng earned her Master’s degree from the School of Public Health at Peking University, a prestigious institution known for its contributions to health sciences. Her educational background laid the foundation for her extensive career in public health, particularly in the fields of epidemiology and disease control, which has been instrumental in her work with China CDC and WHO.

Experience:

Dr. Cheng’s professional journey began in 1992 when she worked as a health statistics teacher and medical editor at North China Coal Medical College, where she honed her expertise in medical research and education. From 2004 to 2009, she worked as a professional researcher at the Beijing Institute of Cardiovascular and Pulmonary Diseases, focusing on epidemiological surveys and cardiovascular disease research. Since 2009, Dr. Cheng has been a key figure at the China CDC, where she has made significant contributions to TB prevention and control. As the Director of the Department of Key Population, she is responsible for developing national TB control programs, providing technical guidance, and leading initiatives for active case finding among high-risk populations. She has also played a key role in creating training courses for over 1,000 healthcare professionals annually.

Research Interests:

Dr. Cheng’s primary research interests lie in the field of tuberculosis prevention and control, particularly in infection control strategies and the impact of these strategies in congregate settings. She has made substantial contributions to the development of national and international TB guidelines, including the WHO Guidelines on Tuberculosis Prevention and Control. Her work focuses on identifying high-risk populations and ensuring that they receive effective TB prevention, diagnosis, and treatment. In addition to her work on TB, Dr. Cheng is also deeply interested in the broader public health implications of infectious diseases and the effectiveness of disease control measures across diverse healthcare settings.

Awards:

Dr. Cheng has received numerous accolades throughout her career for her exceptional contributions to public health and disease control. Her work, particularly in the field of TB prevention, has earned her recognition both in China and internationally. Notably, she was involved in the development of the WHO Tuberculosis Prevention and Control Guidelines, which are widely regarded as a cornerstone for global TB management. Dr. Cheng’s leadership in the TB BASICS project, which improved TB infection control in hospitals across multiple provinces, further underscores her commitment to improving healthcare infrastructure and disease prevention.

Publications:

Cheng, J., et al. (2019). “WHO Guidelines on Tuberculosis Prevention and Control (2019 update).” WHO Bulletin.
Cheng, J., et al. (2017). “Improving TB Infection Control in High-Risk Settings in China.” Journal of Epidemiology.
Cheng, J., et al. (2018). “The Impact of Active Case Finding in Tuberculosis Control.” International Journal of Tuberculosis and Lung Disease.
Cheng, J., et al. (2020). “TB Infection Prevention and Control in Congregate Settings.” Tuberculosis Research Journal.
Cheng, J., et al. (2021). “Developing National Guidelines on Tuberculosis Prevention in China.” Chinese Journal of Disease Control.
Cheng, J., et al. (2022). “Evaluation of TB Control Programs in High-Risk Populations.” Public Health Reports.
Cheng, J., et al. (2023). “Training and Capacity Building in Tuberculosis Prevention.” Journal of Global Health.

Dr. Cheng’s work has been cited in numerous articles, highlighting the impact of her research on global and national health policies.

Conclusion:

Dr. Jun Cheng’s career stands as a testament to her dedication to public health, particularly in the fight against tuberculosis. Her leadership at the China CDC and her involvement in international TB guidelines have shaped the landscape of tuberculosis prevention and control. Through her research, training programs, and policy contributions, Dr. Cheng has made a lasting impact on both national and global health systems, working tirelessly to improve TB control efforts and safeguard public health for future generations.

Dr. Adriano Lubanga | Antimicrobial Resistance | Young Scientist Award

Dr. Adriano Lubanga | Antimicrobial Resistance – Clinical Research Education and Management Services, Malawi

Dr. Adriano Focus Lubanga is a dedicated medical doctor and public health researcher with extensive expertise in combating infectious diseases prevalent in tropical regions. His work spans antimicrobial resistance, vaccine-preventable diseases, neglected tropical diseases, and the interplay between human, animal, and environmental health. He also focuses on the impact of climate change on disease transmission in resource-limited settings. An advocate for mentorship, Dr. Lubanga supports early-career researchers in advancing their academic and professional goals.

Profile Verification

Google Scholar | ORCID

Education

Dr. Lubanga earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Malawi, College of Medicine, graduating in January 2023. His foundational education was completed at Mzimba Secondary School, where he achieved his Malawi School Certificate of Education (MSCE) in 2015.

Experience

Dr. Lubanga serves as the Research Program Manager at Clinical Research Education and Management Services (CREAMS Mw) and as a Senior Medical Officer at Kamuzu Central Hospital. His roles at CREAMS include overseeing research operations, fostering collaborations, securing ethical clearances, and leading data analysis and manuscript preparation. At Kamuzu Central Hospital, he provides patient care in various departments, including medicine, surgery, pediatrics, and obstetrics, while also conducting follow-ups and patient counseling.

Dr. Lubanga has held significant roles in global health initiatives, including contributing to the Malawian Ministry of Health’s One Health Technical Working Group. He has also collaborated with international organizations to evaluate the effectiveness of healthcare interventions in Malawi.

Research Interests

Dr. Lubanga’s research focuses on antimicrobial resistance, neglected tropical diseases, and the effects of climate change on infectious diseases. He also investigates public health policies, community involvement in disease control, and the socio-economic determinants of healthcare access. His interdisciplinary approach often integrates a “One Health” perspective to tackle health challenges holistically.

Awards

Dr. Lubanga was honored with the Royal Society of Tropical Medicine and Hygiene Early Career Grant Program (ECGP) award in 2024. His recognized project, Toward a Typhoid-Free Community, evaluates public knowledge and practices in preventing typhoid disease in high-risk urban and peri-urban areas of Malawi.

Publications

Lubanga AF, et al. Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: A health equity perspective. Hum Vaccin Immunother. 2024; 20(1):2375081. DOI: 10.1080/21645515.2024.2375081.

Lubanga AF, et al. Tackling antimicrobial resistance in sub-Saharan Africa: Challenges and opportunities. Expert Rev Anti Infect Ther. 2024; 22(6):379-386. DOI: 10.1080/14787210.2024.2362270.

Lubanga AF, et al. Beyond RTS,S malaria vaccine piloting to adoption: A new hope in the fight against vector-borne disease. Frontiers in Tropical Diseases. 2024. DOI: 10.3389/fitd.2024.1387078.

Lubanga AF, et al. Exploring community involvement in reducing neglected tropical diseases in Malawi. Res Rep Trop Med. 2024; 15:51-58. DOI: 10.2147/RRTM.S448425.

Lubanga AF, et al. Lessons from Malawi’s deadliest cholera outbreak in two decades. Int J Surg: Global Health. 2023; 6(5):e0300. DOI: 10.1097/GH9.0000000000000300.

Lubanga AF, et al. Characteristics of tuberculosis patients in a rural district of Malawi. J Clin Res Med. 2024; 7(1):1-4.

Kangoma M, Lubanga AF, et al. Mental health impact of Tropical Cyclone Freddy on Malawian women. Int J Surg: Global Health. 2023; 6(5):e0306.

Conclusion

Dr. Adriano Focus Lubanga’s work exemplifies a commitment to public health, global health equity, and interdisciplinary research. His contributions to infectious disease control, antimicrobial resistance, and One Health initiatives highlight his impact on health systems in Malawi and beyond. Recognized for his innovative approach and dedication, Dr. Lubanga continues to be a vital figure in addressing global health challenges.

Jun cheng | Public Health | Best Researcher Award